Cyclacel announces 1-for-16 reverse stock split effective May 12, 2025 to meet Nasdaq bid price requirement

Bio Green Med Solution, Inc.

Reverse split ratio of 1-for-16; effective May 12, 2025 at market open.
Pre-split shares: 356,357,531; post-split shares: 22,272,346 (rounded).
No fractional shares; rounding rules apply for shares half or more/less than half.
CUSIP changes to 23254L884; trading symbol remains CYCC on Nasdaq Capital Market.
Split approved by board and stockholders to regain compliance with Nasdaq minimum bid price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.